-
integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/screening-and-diagnosis
January 01, 2018 - Referral to Treatment—provide a referral to therapy or additional treatment. … setting for substance use treatment services or specific components of care. … Don’t assume that one treatment model is appropriate for all patients. … Treatment Improvement Protocol 63: Medications for Opioid Use Disorder. … Principles of Substance Use Treatment
Delivering Effective, Low Barrier Treatment
-
digital.ahrq.gov/2020-year-review/research-summary/user-centered-decision-support-tools-chronic-pain
January 01, 2020 - clinicians’ perceptions and judgments of pain to increase use of guideline-based patient assessment and treatment … A holistic approach is important to understand the best treatment plan for the patient, whether it involves … opioid misuse is a public health crisis, clinicians are eager for guidance to navigate appropriate treatment … The second tool—the Chronic Pain Treatment Tracker—is used to track treatment and outcomes for patients … These designs help clinicians overcome barriers of technologies that are not user friendly for treatment
-
integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/chronic-pain-management
January 01, 2012 - As needed, they incorporate nonpharmacologic and complementary therapies into the treatment plan and … treatment (MAT) services should be specified as part of the treatment plan. … Providers may want to recommend nonpharmacologic treatments, such as therapeutic exercise, physical therapy … , cognitive-behavioral therapy, and complementary and alternative medicine. 1 If pharmacologic treatment … is clinically indicated, it is best to use Nonopioid Treatments for Chronic Pain (PDF—1.53 MB).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments.pdf
December 23, 2023 - Adverse Events Associated with COVID-19 Pharmaceutical Treatments
Evidence-based Practice Center … Rapid Review Protocol
Project Title: Adverse Events Associated with COVID-19 Pharmaceutical
Treatments … rapid product to
summarize the best available evidence on adverse events associated with authorized
treatments … Review is to provide an overview of the risk, severity, and
timing of adverse events associated with treatments … Interleukin Antagonist: Anakinra
Comparators Placebo, treatment as usual, no treatment Active comparators
-
digital.ahrq.gov/ahrq-funded-projects/monitoring-intensification-treatment-hyperglycemia-and-hyperlipidemia
January 01, 2023 - Monitoring Intensification of Treatment for Hyperglycemia and Hyperlipidemia
Project … Test the hypothesis that the measure of treatment intensification developed in the first objective is … They were successful in using NLP tools to identify treatment intensification in narrative text. … The project used a retrospective cohort design study to evaluate the treatment of over 20,000 patients … Analysis showed that treatment intensification was more likely with high HbA1c and LDL levels.
-
effectivehealthcare.ahrq.gov/products/ptsd-adult-treatment/research-protocol
-
integrationacademy.ahrq.gov/news-and-events/news/opioid-use-disorder-resources-2018-updates
January 11, 2018 - New Opioid Treatment Resources for Emergency Department Clinicians (National Institute on Drug Abuse … )— NIDA released new resources for those implementing buprenorphine treatment in emergency department … Science to Medicine: Medication Treatment for Opioid Use Disorder (National Institute on Drug Abuse) … Telemedicine and Prescribing Buprenorphine for the Treatment of Opioid Use Disorder (PDF—118 KB) (U.S … steps needed to access care and the signs of quality treatment centers.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
August 01, 2020 - Psychosocial combined with agonist
maintenance treatments versus agonist
maintenance treatments alone … The therapeutic workplace to promote
treatment engagement and drug abstinence
in out-of-treatment injection … Opioid substitution therapy: Lowering
the treatment thresholds. … Psychosocial combined with agonist
maintenance treatments versus agonist
maintenance treatments alone … The therapeutic workplace to promote
treatment engagement and drug abstinence
in out-of-treatment injection
-
psnet.ahrq.gov/issue/heparin-improving-treatment-and-reducing-risk-harm
July 28, 2021 - Newspaper/Magazine Article
Heparin: improving treatment and reducing risk of harm … Citation Text:
Heparin: improving treatment and reducing risk of harm. … URL
Cite
Citation
Citation Text:
Heparin: improving treatment
-
digital.ahrq.gov/ahrq-funded-projects/knowledge-engineering-decision-support-osteoporosis/annual-summary/2012
January 01, 2012 - 2014
AHRQ Funding Amount
$805,680
Summary: There are many barriers to the diagnosis and treatment … , and uncertainty about when to initiate treatment. … While computerized clinical-decision support has the potential to improve appropriate treatment rates … (Ongoing)
Pilot the decision support tool for initiating osteoporosis treatment. … LaFleur is working toward her long-term career goal of identifying and preventing drug-therapy failures
-
integrationacademy.ahrq.gov/products/playbooks/opioid-use-disorder/implement-mat-for-oud/payment-and-reimbursement
January 01, 2018 - However, the decision to engage in behavioral therapy or psychosocial support should result from shared … Prior authorizations that are contingent on participation in behavioral therapies conflict with expert … not to limit access to medication because a patient is unwilling or unable to engage in behavioral therapy … standardize requirements across health plans, significant progress still needs to be made. 3
Step therapy … Principles of Substance Use Treatment
Delivering Effective, Low Barrier Treatment
-
digital.ahrq.gov/ahrq-funded-projects/implementing-low-literacy-multimedia-information-technology-system-enhance/annual-summary/2012
January 01, 2012 - , self-efficacy, adherence to recommended treatment, and HRQL. … surveillance care and HRQL during the early post-treatment surveillance period (3 months after treatment … At the conclusion of their in-clinic cancer treatments, participants in the intervention arm also received … The survivorship care plan summarized the cancer treatments they had received and provided appropriate … was designed to minimize the interruptions in care that can occur when patients complete their cancer treatments
-
digital.ahrq.gov/ahrq-funded-projects/implementing-low-literacy-multimedia-information-technology-it-system-enhance/annual-summary/2011
January 01, 2011 - At the conclusion of their in-clinic cancer treatments, participants in the intervention arm also receive … The survivorship care plan summarizes the cancer treatments they have received and provides appropriate … is designed to minimize the interruptions in care that can occur when patients complete their cancer treatments … , self-efficacy, adherence to recommended treatment, and HRQL. … surveillance care and HRQL during the early post-treatment surveillance period (3 months after treatment
-
psnet.ahrq.gov/issue/minimising-treatment-associated-risks-systemic-cancer-therapy
December 22, 2021 - Review
Minimising treatment-associated risks in systemic cancer therapy. … Minimising treatment-associated risks in systemic cancer therapy. … This article reviews the high-risk process of cancer drug therapy and describes how integrating pharmacist … Minimising treatment-associated risks in systemic cancer therapy. … March 1, 2023
Use of therapeutic outcomes monitoring method for performing of pharmaceutical
-
integrationacademy.ahrq.gov/sites/default/files/2020-06/mat_for_oud_environmental_scan_volume_1_1.pdf
January 01, 2020 - enhancement therapy,
or peer-delivered recovery support services.3 The psychosocial treatment component … Front Lines of Addiction, Bachhuber, et al., point out that:
…despite the increasingly effective treatments … suboxone programs also are offering
"higher level care," such as daily, witnessed dosing and daily therapeutic … Treatments for Substance Use
Disorders. … Center for Substance Abuse Treatment. Considerations for the provision of e-therapy.
-
digital.ahrq.gov/program-overview/research-stories/technology-support-personalized-care-decisions-breast-cancer
January 01, 2023 - Technology to Support Personalized Care Decisions for Breast Cancer Treatment
Theme:
Engaging … in women, but treatment decisions can be complex. … Each treatment option brings different benefits, risks (e.g., short- and long-term side effects), and … implications (e.g., treatment duration) for the patient. … Women need to be fully informed of all viable treatment options, and their treatment decisions should
-
meps.ahrq.gov/data_files/publications/st539/stat539.shtml
February 01, 2022 - STATISTICAL BRIEF #539: Healthcare Expenditures for Treatment of Mental
Disorders: Estimates … The number of females with expenses for the treatment of
mental disorders … The number of females with expenses
for the treatment for mental disorders was … Total expenditures for the treatment of mental disorders, by
age and sex … Almost one-fifth
(19.1 percent) of mental disorder treatment expenditures were
-
digital.ahrq.gov/ahrq-funded-projects/using-information-technology-provide-measurement-based-care-chronic-illness/annual-summary/2011
January 01, 2011 - Despite the development of effective treatments over the last 30 years, evidence from practice settings … continues to show inadequate antidepressant medication treatment in dosage and duration. … The IT system also provided decision support during each medication treatment phase and helped prevent … Their primary concern was the increased time burden, in both the length and number of treatments visits … The first study was designed to provide a systematic evaluation of changes in treatment patterns in the
-
integrationacademy.ahrq.gov/sites/default/files/2022-11/Medications%20for%20Alcohol%20Use%20FAQ.pdf
January 01, 2022 - hypotension,
difficulty breathing)
Frequency • Twice daily (should be
titrated slowly to reach
desired therapeutic … doses)
• 600-1,800 mg once daily
or divided twice per day
(higher doses may be
needed for a therapeutic … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician. … https://effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
August 01, 2022 - pharmacologic treatments and nonpharmacologic therapy for outcomes
related to pain, function, pain relief … , usual care, attention control, and no treatment up to 4 weeks after
treatments (KQ 3). … One new
original observational study of nonpharmacologic therapies (KQ 3) met our inclusion criteria … What are the effects of prescribing opioid therapy versus not
prescribing opioid therapy for acute treatment … invasive
treatments (surgical
interventions, etc.),
and preventive
(prophylactic)
treatment